Flumazenil to reverse sedation during depression treatment
Treatments studied
Part of Mental health clinical trials.
This trial tests whether flumazenil (a medication that reverses sedation from anti-anxiety drugs) can safely help patients wake up faster after electroconvulsive therapy (ECT), a treatment for severe depression. The goal is to see if it improves recovery time without causing problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with depression (including bipolar depression) and are currently in a depressive episode
- You are admitted to a participating hospital in the Mental Health Services of the Capital Region of Denmark
- Your psychiatrist has referred you for ECT and you have agreed to it
- You are currently taking anti-anxiety medications (like benzodiazepines) or sleeping pills at a minimum dose
- You are voluntarily receiving ECT (not involuntary treatment)
- You can read and understand Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two anesthesia medicines—esketamine plus propofol versus methohexital—for people receiving ECT (electroconvulsive therapy) for severe depression. The goal is to see which anesthesia approach works better and is safer for patients during ECT.
This study tests whether a medication called fenfluramine can help researchers understand depression by measuring brain activity. Participants with moderate-to-severe depression or healthy volunteers will undergo brain scans while receiving this medication to help scientists learn more about how serotonin (a brain chemical) relates to depression.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This study tests whether using a virtual reality mindfulness program, added to your usual depression care, can help people whose depression hasn't responded to standard treatments.
This trial tests if giving flumazenil after remimazolam sedation can help people think more clearly after hip replacement surgery. If you are having a planned hip replacement and are generally healthy, this study might be for you.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.